Stay updated on Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    No significant changes detected on the Study Details page; the study overview, objectives, eligibility criteria, and plan appear unchanged. Any minor formatting differences are not considered impactful.
    Difference
    0.4%
    Check dated 2025-11-03T01:32:17.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    - Added a government operating status notice and a link to official sources for NIH Clinical Center status. - Updated version to v3.2.0 and removed reference to v3.1.0.
    Difference
    2%
    Check dated 2025-10-05T10:39:43.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    - Terminology updated: 'Clear cell renal carcinoma' replaced with 'Clear cell carcinoma of kidney'. - Version bumped from v3.0.2 to v3.1.0.
    Difference
    0.2%
    Check dated 2025-09-28T03:27:08.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision bumped from v3.0.1 to v3.0.2; the 'Back to Top' link was removed, a minor UI change.
    Difference
    0.2%
    Check dated 2025-09-13T17:45:46.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, and a 'Back to Top' feature has been added.
    Difference
    0.2%
    Check dated 2025-09-06T15:30:23.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as detailed information on various proteins and antibodies, while removing several related medical topics and terms.
    Difference
    2%
    Check dated 2025-08-30T12:16:14.000Z thumbnail image

Stay in the know with updates to Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page.